METHOD OF TREATING PATIENTS WITH SCAPULOHUMERAL PERIARTHROSIS Russian patent published in 2015 - IPC A61K31/167 A61K31/522 A61K31/573 A61K31/714 A61P19/02 

FIELD: medicine.

SUBSTANCE: 10-day conventional drug therapy comprising a daily vascular therapy by intravenous drop-by-drop administration of Trental 5 ml dissolved in 0.9% normal saline 200 ml is followed by a local therapeutic exposure on the involved shoulder joint. That is ensured by intramuscular administration of a therapeutic mixture containing Depot-Medrol 1 ml - 40 mg, 2% lidocaine hydrochloride 6 ml - 120 mg and cyanocobalamine 3 ml - 1.5 ml into trigger areas of supraspinous, infraspinous, deltoid and subscapular muscles. Administering the therapeutic mixture follow the schedule: on the first therapeutic day, the therapeutic mixture is injected into the trigger areas of supraspinous and infraspinous muscles in an amount of 5 ml into each muscle once a day; on the second therapeutic day, the therapeutic mixture is injected into the trigger areas of deltoid and subscapular muscles in an amount of 5 ml into each muscle once a day; from the third to ninth therapeutic day, the therapeutic mixture is introduced in a dose of 10 ml every second day into the trigger areas of the subscapular muscle.

EFFECT: method enables increasing the clinical effectiveness in the patients with scapulohumeral periarthrosis by recovering the shoulder joint function with reducing the recurrent pain syndrome considerably.

1 ex